Prevalence of statin intolerance: a meta-analysis
Aims Statin intolerance (SI) represents a significant public health problem for which precise
estimates of prevalence are needed. Statin intolerance remains an important clinical …
estimates of prevalence are needed. Statin intolerance remains an important clinical …
[HTML][HTML] Effects of statin therapy on glycemic control and insulin resistance: A systematic review and meta-analysis
L Alvarez-Jimenez, F Morales-Palomo… - European journal of …, 2023 - Elsevier
Aims To update the evidence about the diabetogenic effect of statins. Methods We searched
for randomized-controlled trials reporting the effects of statin therapy on glycosylated …
for randomized-controlled trials reporting the effects of statin therapy on glycosylated …
High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD) a randomized superiority trial
Background: Current guidelines call for high-intensity statin therapy in patients with
cardiovascular disease on the basis of several previous “more versus less statins” trials …
cardiovascular disease on the basis of several previous “more versus less statins” trials …
[HTML][HTML] 2017 Taiwan lipid guidelines for high risk patients
YH Li, KC Ueng, JS Jeng, MJ Charng, TH Lin… - Journal of the Formosan …, 2017 - Elsevier
In Taiwan, the prevalence of hyperlipidemia increased due to lifestyle and dietary habit
changes. Low density lipoprotein cholesterol (LDL-C) and non-high density lipoprotein …
changes. Low density lipoprotein cholesterol (LDL-C) and non-high density lipoprotein …
A comprehensive review on the lipid and pleiotropic effects of pitavastatin
A Sahebkar, N Kiaie, AM Gorabi, MR Mannarino… - Progress in Lipid …, 2021 - Elsevier
Abstract The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or
statins, are administered as first line therapy for hypercholesterolemia, both in primary and …
statins, are administered as first line therapy for hypercholesterolemia, both in primary and …
Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and …
Objective To compare the efficacy of different statin treatments by intensity on levels of non-
high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular …
high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular …
Effect of pitavastatin on glucose, HbA1c and incident diabetes: a meta-analysis of randomized controlled clinical trials in individuals without diabetes
AJ Vallejo-Vaz, SRK Seshasai, K Kurogi, I Michishita… - Atherosclerosis, 2015 - Elsevier
Aims Whether adverse effect of statins on glycaemic indices is common to all statins remains
controversial and as yet data for pitavastatin are limited. We sought to assess the effects of …
controversial and as yet data for pitavastatin are limited. We sought to assess the effects of …
Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis
S Erqou, CC Lee, AI Adler - Diabetologia, 2014 - Springer
Aims/hypotheses Current evidence indicates that statins increase the risk of incident
diabetes; however, the relationship between statins and glycaemic control in people with …
diabetes; however, the relationship between statins and glycaemic control in people with …
[HTML][HTML] Efficacy and safety of ticagrelor versus clopidogrel in acute coronary syndrome in Taiwan: a multicenter retrospective pilot study
IC Chen, CH Lee, CC Fang, TH Chao… - Journal of the chinese …, 2016 - Elsevier
Background The efficacy and safety of ticagrelor compared with clopidogrel in acute
coronary syndrome has not previously been evaluated in an Eastern Asian population …
coronary syndrome has not previously been evaluated in an Eastern Asian population …
Pitavastatin for lowering lipids
SP Adams, N Alaeiilkhchi… - Cochrane Database of …, 2020 - cochranelibrary.com
Background Pitavastatin is the newest statin on the market, and the dose‐related magnitude
of effect of pitavastatin on blood lipids is not known. Objectives Primary objective To quantify …
of effect of pitavastatin on blood lipids is not known. Objectives Primary objective To quantify …